###### Strengths and limitations of this study

-   Nationwide, population-based study on occurrence and short-term mortality of infective endocarditis in Finland.

-   Decade long population coverage (over 42 million person-years), using mandatory nationwide registries.

-   The data are extracted from medical records: the availability of the data depends on the completeness and detail of the medical record.

-   Retrospective design without access to detailed clinical data.

Introduction {#s1}
============

Infective endocarditis (IE) is a life-threatening disease associated with high morbidity and mortality. The incidence of IE has reported to be 2--8 cases per 100 000 person-years.[@R1] Previous studies have found the incidence of IE to be increasing in Europe[@R5] while in the USA, both stable[@R8] and increasing IE rate[@R12] have been described. The epidemiologic profile of IE is changing due to population changes such as lengthening of life expectancy, change in risk factors and development of diagnostic methods. Furthermore, people are exposed to increasing amount of healthcare procedures.[@R7] Increasing number of cardiac procedures with implanted prosthetic material is associated with increasing IE incidence.[@R8] Improved survival of the patients with a predisposing factor to severe bacterial infections, such as congenital heart disease or prosthetic heart valve may also contribute to the IE incidence.[@R20] The short-term mortality of IE has been reported to be 10%--24%.[@R3] Despite the development of treatment methods, the majority of studies have found short-term mortality to be stable over the last years[@R5] although trend for increased mortality is also reported.[@R7] Population-based sex-specific and age-specific epidemiology and trends of IE are however inadequately known. The purpose of this nationwide study was to study recent temporal trends and age and sex differences in the occurrence and short-term mortality of IE in Finland.

Methods {#s2}
=======

Study design and data collection {#s2a}
--------------------------------

This population-based study included adult patients (≥18 years of age) hospitalised for IE in Finland during 2005--2014. Data were collected retrospectively from the nationwide Care Register for Health Care (CRHC) database maintained by the Finnish National Institute for Health and Welfare.[@R21] This obligatory database automatically collects hospital discharge data including individual baseline data (eg, age, sex, admission, operation and discharge dates), discharge diagnoses (International Classification of Diseases \[ICD\]-10) and operational codes (Nordic Classification of Surgical Procedures) of all hospital admissions in Finland. Each individual in Finland has unique social security identification number allowing for patient specific data collection and follow-up. We studied patients discharged from medical or surgical care units of all 38 hospitals (including five university hospitals) treating acute IE between 1 January 2005 and 31 December 2014. Surgical operations of the heart or ascending aorta and pacemaker implantations or changes performed 1 year prior to the admission due to IE during study period were recognised from CRHC.

Data of Finnish population at risk (42 754 847 person-years) and 30-day mortality data of patients with IE admission were obtained from Statistics Finland.

Definitions {#s2b}
-----------

Patients with discharge diagnosis of IE (ICD-10 codes I33, I38 and I39) as primary (66.3%), secondary (24.1%) or tertiary (9.6%) cause of admission were included in the study. One IE admission/patient/year was included. The annual incidence rate of admissions per calendar year was calculated using age-specific, year-specific and sex-specific population data and standardised with European 2013 standard population using direct method. Charlson comorbidity index (CCI) score was calculated as previously described.[@R22]

Validation of infective endocarditis diagnoses {#s2c}
----------------------------------------------

Specificity of ICD-10 IE codes (I33, I38 or I39) was studied in a subgroup of patients admitted to the Turku University Hospital. Patient records (including, eg, laboratory, microbiology, pathological and imaging data) of randomly selected patients (n=188; 74% male, mean age 59.7 years) admitted during 2005--2014 were reviewed to determine whether the modified Duke criteria for IE[@R23] were fulfilled. Of 188 reviewed patients, 182 fulfilled the criteria (definitive IE in 122 and possible IE in 60 patients) resulting to specificity of 96.8%.

Statistical analysis {#s2d}
--------------------

Patient characteristics were analysed for included admissions using χ^2^ and t-tests as appropriate. Negative binomial regression with logarithm of corresponding population as an offset parameter was used for analysis of incidence rates. Incidence rate ratios (IRR) were estimated using regression models with number of admissions as dependent variable and sex, age and year of admission as independent variables. Mortality of first IE admission in study period was studied with Cox regression modelling. Potential association modifications by age, sex and study year were studied with interaction analyses. Variables associated with mortality at significance level of p\<0.2 in univariate analysis were included in multivariate Cox modelling. Otherwise p\<0.05 was considered statistically significant. Statistical analyses were performed with the SAS system V.9.4.

Patient and public involvement {#s2e}
------------------------------

Patients or public were not involved in the design or conduction of this study.

Results {#s3}
=======

Patient characteristics {#s3a}
-----------------------

There were 2611 IE admissions occurring to 2331 individuals in the study period. Of IE admissions, 1780 (68.2%) occurred to men and 831 (31.8%) to women. The mean age of the patients with IE was 60.0 years (SD 18.3, range 18--97) ([figure 1](#F1){ref-type="fig"}). Women with IE were older than men (mean age 62.0 SD 20.7 vs 59.0 SD 17.1, p=0.0004) and had higher comorbidity burden (CCI score ≥1 in 46.7% vs 42.5% in men, p=0.047). Within 1 year prior to admission with IE, 7.8% of patients had open cardiac surgery, prosthetic valve was implanted in 5.5% and 0.8% underwent coronary artery bypass grafting. Pacemaker was implanted or pacemaker generator changed in 1.5% of patients within 1 year before IE admission.

![Age distribution of patients with infective endocarditis. Sex-specific distribution is presented as relative proportion within bars.](bmjopen-2018-026811f01){#F1}

Occurrence {#s3b}
----------

The crude annual incidence rate of IE admissions was 6.11 cases per 100 000 person-years (95% CI 5.86 to 6.36) and standardised incidence rate was 6.33 cases per 100 000 person-years (95% CI 6.09 to 6.57). The crude incidence rate in men was 8.57 cases per 100 000 person-years (95% Cl 8.18 to 8.98) and 3.78 cases per 100 000 person-years in women (95% CI 3.53 to 4.04). Standardised rates were 9.46 cases per 100 000 person-years (95% CI 9.04 to 9.89) in men and 3.67 cases per 100 000 person-years (95% CI 3.45 to 3.94) in women. Overall incidence rate of IE was lowest in youngest study population, somewhat higher in population aged 30--49 years and increased progressively with age in older population ([figure 2](#F2){ref-type="fig"}). In men, IE incidence rate increased more steadily with ageing than in women. Increasing IE incidence rate was observed beginning from 60 years of age in women ([figure 2](#F2){ref-type="fig"}). Men had significantly higher risk of IE compared with women overall (IRR 2.49; CI 2.22 to 2.79; p\<0.0001). Sex difference in IE risk was present in patients aged ≥30 years, was most prominent in population aged 40--59 years (IRR 4.49; CI 3.68 to 5.48; p\<0.0001) and decreased thereafter ([figure 3](#F3){ref-type="fig"}).

![Occurrence of infective endocarditis admissions in general adult population. Total (A) and sex-specific (B) annual incidence rates (per 100 000 person-years) by age. Error bars represent upper limits of 95% CI.](bmjopen-2018-026811f02){#F2}

![Sex differences in relative risk for infective endocarditis by age in general adult population. Error bars represent 95% CI. IRR, incidence rate ratio.](bmjopen-2018-026811f03){#F3}

Annual trends {#s3c}
-------------

The total incidence rate of IE admissions varied from 5.71/100 000 in 2005 to 7.08/100 000 in 2012 with estimated average increase of 2.13% per year (IRR 1.021; 95% CI 1.002 to 1.042, p=0.035) during the study period ([figure 4](#F4){ref-type="fig"}). Overall incidence trend was similar between sexes (interaction p=0.725). There was however a significant difference in evolution of IE admission trends regarding age (interaction p=0.003, [table 1](#T1){ref-type="table"}). Increase in IE occurrence was driven by significant 7.2%--7.6% annual increase in population aged 18--39 years (p=0.002). In population aged 40--49, there was a 3.8% annual change in occurrence (p=0.08). In older population, however, there was no clear trend during study period in IE incidence rate. Proportion of patients with prosthetic valve surgery or pacemaker operation within 1 year prior to IE varied by study year ([figure 5](#F5){ref-type="fig"}) but had no significant trend (p=NS for both). Comorbidity burden (CCI score) remained also similar during study period.

![Trends in annual incidence rate of infective endocarditis rate in general adult population.](bmjopen-2018-026811f04){#F4}

![Trends of prosthetic valve surgery and pacemaker operations within a year prior to infective endocarditis admission.](bmjopen-2018-026811f05){#F5}

###### 

Trends in annual incidence rate of infective endocarditis admissions during 2005--2014 by age

  Age (years)   Estimated annual change %   95% CI          P value
  ------------- --------------------------- --------------- ---------
  18--29        7.62                        2.67 to 12.81   0.002
  30--39        7.24                        2.61 to 12.07   0.002
  40--49        3.82                        −0.50 to 8.32   0.084
  50--59        0.52                        −2.60 to 4.01   0.767
  60--69        0.20                        −2.75 to 3.18   0.910
  70--79        −2.05                       −5.39 to 1.42   0.244
  80--          1.32                        −2.23 to 5.00   0.470
  Total\*       2.13                        0.15 to 4.15    0.035

\*Adjusted for age.

Short-term mortality {#s3d}
--------------------

Thirty-day all-cause mortality after IE admission was 11.3%. Mortality increased significantly with ageing ([figure 6](#F6){ref-type="fig"}, [table 2](#T2){ref-type="table"}). In patients aged \<50 years mortality was 4.8%, in patients aged 50--69 years mortality was 10.9% with further increase to 16.0% in the oldest (\>70 years) patients (p\<0.0001). Age difference in mortality was similar in both sexes (interaction p=0.145). Mortality was similar between men and women ([table 2](#T2){ref-type="table"}). There was no significant annual trend for 30-day mortality with similar occurrence in both sexes and different age groups (interaction p\>0.65 for both). Thirty-day mortality increased with comorbidity burden (CCI) but was similar regardless of prosthetic valve implantation or pacemaker operation a year prior to IE ([table 2](#T2){ref-type="table"}).

![Cumulative total (A) and age-stratified (B) all-cause 30-day mortality after infective endocarditis admission.](bmjopen-2018-026811f06){#F6}

###### 

Predictors of 30-day all-cause mortality after first infective endocarditis admission during study period (n=2331)

  Parameter                           Univariate models     Multivariate model                         
  ----------------------------------- --------------------- -------------------- --------------------- ----------
  Female sex                          1.19 (0.93 to 1.53)   0.170                1.09 (0.84 to 1.40)   0.532
  Age group (years)                                         \<0.0001                                   \<0.0001
   18--49                             Reference                                  Reference             
   50--69                             2.34 (1.55 to 3.58)   \<0.0001             2.05 (1.35 to 3.13)   0.001
   ≥70                                3.50 (2.35 to 5.22)   \<0.0001             2.83 (1.88 to 4.24)   \<0.0001
  Charlson comorbidity index                                \<0.0001                                   \<0.0001
   0                                  Reference                                  Reference             
   1                                  2.25 (1.67 to 3.02)   \<0.0001             2.00 (1.49 to 2.70)   \<0.0001
   ≥2                                 2.83 (2.11 to 3.79)   \<0.0001             2.40 (1.79 to 3.23)   \<0.0001
  Prosthetic valve implantation\*     0.67 (0.36 to 1.26)   0.217                --                    
  Pacemaker operation\*               1.00 (0.37 to 2.70)   0.993                --                    
  Study year (per 1 year increment)   0.98 (0.94 to 1.02)   0.280                --                    

\*Within a year prior to endocarditis admission.

Discussion {#s4}
==========

This nationwide population-based study explored temporal trends and age and sex differences in the occurrence and short-term mortality of IE in general adult population. The standardised incidence rate of IE admissions was 6.3 cases per 100 000 person-years in Finland. This is in concordance with previous studies from other Western countries reporting incidence rates of 2--8 per 100 000 person-years.[@R1] The likelihood of IE in our study was lowest in the youngest study population, somewhat higher in population aged 30--49 years and increased progressively with age in older population. This is likely to be related with the higher risk for degenerative valve diseases and coexisting medical conditions predisposing to severe bacterial infections[@R20] in older patients.

We found the occurrence of IE to be rising in adults \<40--50 years and this reflects to an increase of the overall IE incidence rate. However, in older population there was no significant trend in IE occurrence. Curiously, studies from US, Denmark and Spain have reported contradictory results with increasing IE rates in older patients.[@R6] Reason for this discrepancy remains to be determined. One plausible explanation might be increasing drug abuse among young Finnish adults.[@R25] The mean age of the patients with IE in our study was 60 years. The patients were younger than in several previous population-based studies.[@R2] This might reflect the easy access to healthcare system for drug abusers in Finland.

Ternhag *et al* [@R5] reported a nationwide study of IE episodes during 1997--2007 based on register data from Sweden. They found IE incidence corresponding to our findings, 7.7/100 000, and the incidence rate also increased during the study period. The mean age was 66 years which is higher than in our study. In Denmark in a similar study setting, the incidence rate increased from 3.9 to 7.6/100 000 during the study period 1994--2011 with a mean age of 63 years.[@R6]

Surgical and dental procedures may cause bacteremia linked to IE. Guidelines for IE prophylaxis published by the American Heart Association in 2007[@R27] and by the European Society of Cardiology in 2009[@R28] restricted the pre-procedural antibiotic usage. In UK NICE Guidelines of 2008 went a step further with abolishing prophylactic antibiotic usage.[@R29] This change has been associated with increased occurrence of IE in the UK,[@R30] the Netherlands[@R10] and in Germany.[@R18] A recent US study showed decrease in prescription of prophylactic antibiotics and concurrent increase in IE among high-risk individuals following guideline change.[@R31] Previous studies from the USA[@R8] and Canada[@R32] have however found no association of endocarditis prophylaxis guidelines and overall IE occurrence. In agreement, we found occurrence of IE admissions to increase with stable rate between 2005 and 2014 suggesting that guideline changes did not have a major impact to overall occurrence of IE in adult Finnish population. Further studies on antibiotic prophylaxis are however warranted.[@R13]

Our results show that IE admissions are more common in men than in women with 2.5-fold relative risk. This is in line with a recent study of Thornhill *et al* [@R9] that found 2.2-fold odds for IE in men and with previous studies.[@R33] In our study, the sex difference was most prominent in population aged 40--59 years. One likely explanation for male predominance is the increased number of risk factors[@R9] and predisposing medical conditions, such as degenerative valve disease, for IE in men. Furthermore, the intravenous drug use is more common in men.[@R26] Pregnancy-associated endocarditis is likely to contribute for more comparable IE occurrence between sexes in adults \<40 years.[@R36]

Prosthetic valve was implanted in 5.5% of patients and pacemaker was implanted or pacemaker generator changed in 1.5% of patients within 1 year prior to diagnosis of IE. These proportions varied by year, but no significant trend was observed. Previous studies have found the proportion of IE patients with a history of heart valve surgery or implanted pacemakers increasing.[@R7] Notably, previous prosthetic valve replacement is found to increase the odds of IE approximately 70-fold and implanted pacemaker 10-fold.[@R9]

The 30-day all-cause mortality for IE was 11.3% in our study population. This is comparable to 30-day mortality of 10.4% found in a Swedish IE study.[@R5] Previous studies have reported higher in-hospital mortalities.[@R7] In a study among Medicare beneficiaries, the in-hospital mortality rate for IE was 9.1%--11.1% and 30-day mortality rate 14.2%--16.5%.[@R11] We found no significant annual trend for short-term mortality. This is in line with a number of previous studies,[@R5] but trend for increasing short-term mortality has also been reported.[@R7] Reason for non-decreasing short-term IE mortality is unclear. It is possible that improved diagnosis of IE in critically ill patients may offset the improvement of treatment methods. Increasing age and comorbidity burden predicted 30-day mortality in our study population. Age was a strong predictor with 2.8-fold adjusted mortality hazard of patients aged ≥70 years compared with \<50 years old IE patients. Short-term mortality was however similar between sexes in our study population, comparably to previous survey of 1980--2004 in Finland.[@R34]

Strengths and limitations {#s4a}
-------------------------

The present retrospective study is based on a register database and there are thus certain limitations. The diagnoses were made by the treating physicians and access to the detailed clinical data were not available for all study patients. However, the accuracy of the mandatory and centralised nationwide CRHC registry is found to be valid.[@R38] Modified Duke criteria[@R23] are the gold standard for IE diagnosis in Finland. In subgroup analysis of IE patients admitted to tertiary university hospital, we found specificity of ICD-10 codes for IE to be 96.8%. Accordingly, a recent validation study using similar methodology found ICD-10 codes for IE to have 90% sensitivity and 100% specificity.[@R39] It is nevertheless possible that accuracy of ICD-10 codes for IE may differentiate between institutions. We did not have microbiological results of blood or tissue samples of the patients, which limits the conclusions of this study. In addition, risk factors available for analysis were limited (eg, data on intravenous drug use or previous native valve disease were not available). Major strength of our study is the decade long nationwide coverage of total adult population.

Conclusions {#s5}
===========

In conclusion, the occurrence of IE is increasing in young adults, but not in older population in Finland. Men, especially at middle-age, have higher risk for IE than women. The 30-day mortality has remained stable at 11% and was similar between sexes. Mortality increased significantly with ageing and comorbidities.
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